Supplementary Methods 1 from Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer
Year: 2026
Type: supplementary-materials
Abstract: Supplementary Methods: Crystal Structure Determination of Wild-Type EGFR in Complex with Sevabertinib. Xenograft models
Authors: Franziska Siegel, Stephan Siegel, Kristýna Kotýnková, Gizem Karsli Uzunbas, Daniel Korr, Haruna Tomono, Sawyer Andersen, Daniel Denney, Markus Berger, Volker K. Schulze, Timothy A. Lewis, Bethany Kaplan, Sven Golfier, Jérémie Mortier, Roman C. Hillig, Ulf Boemer, Kirstin Petersen, Knut Eis, Sybil Williams, Dominik Rüttinger, Andrew D. Cherniack, Herbert H. Loong, Koichi Goto, Paolo Grassi, Matthew Meyerson, Heidi Greulich
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7122665780